Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hannah Vuong"'
Autor:
Ivan Macciocca, Kate Dunlop, Belinda J McClaren, Fiona Haslam McKenzie, Amy Nisselle, Sylvia A Metcalfe, Clara Gaff, Hannah Vuong
Publikováno v:
Journal of Genetic Counseling. 28:367-377
We aimed to determine capacity and readiness of Australian clinical genetic healthcare professionals to provide genomic medicine. An online survey was administered to individuals with genetic counseling or clinical genetics qualifications in Australi
Autor:
Rawal Jaiessh, Amy Randall, Tram T. Tran, Fiona M. Adam, Daniel Siddle, Iain Gardner, Tanya Parkinson, Manos Perros, David R. Fenwick, Christopher Pickford, Juin Fok-Seang, Charles E. Mowbray, David Howard Williams, Donald Stuart Middleton, Hannah Vuong, Peter T. Stephenson, Michelle Y. Platts, Duncan Hay
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:5246-5249
A series of piperazine derivatives were designed and synthesised as gp120-CD4 inhibitors. SAR studies led to the discovery of potent inhibitors in a cell based anti viral assay represented by compounds 9 and 28. The rat pharmacokinetic and antiviral
Autor:
Gill Allan, Amy Randall, Sandra D. Newman, Romuald Corbau, Charles E. Mowbray, David Howard Williams, Manos Perros, Mike Westby, Duncan Hay, Donald Stuart Middleton, Hannah Vuong, Lyn H. Jones, Rob Webster
Publikováno v:
ChemMedChem. 3:1756-1762
A major problem associated with non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV is their vulnerability to mutations in the allosteric binding site of reverse transcriptase that can result in the development of a resi
Publikováno v:
ChemInform. 25
Autor:
Jaiessh Rawal, David Howard Williams, Donald Stuart Middleton, Michelle Y. Platts, Juin Fok-Seang, Manos Perros, Frederick Calo, Duncan Hay, Christopher Pickford, David R. Fenwick, Tram T. Tran, Hannah Vuong, Fiona M. Adam, Iain Gardner, Tanya Parkinson, Peter T. Stephenson, Amy Randall
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(17)
The synthesis and structure-activity relationship of a series of novel gp120-CD4 inhibitors are described. Pharmacokinetic studies and antiviral spectrum assessment of lead compounds led to the identification of compound 36, a potent gp120-CD4 inhibi
Publikováno v:
Synlett. 1994:171-172